Sensei Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNSE and other ETFs, options, and stocks.About SNSE
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
CEOJohn K. Celebi
CEOJohn K. Celebi
Employees15
Employees15
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded1999
Founded1999
Employees15
Employees15
SNSE Key Statistics
Market cap9.84M
Market cap9.84M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume24.75K
Average volume24.75K
High today$9.50
High today$9.50
Low today$7.80
Low today$7.80
Open price$9.46
Open price$9.46
Volume22.85K
Volume22.85K
52 Week high$18.35
52 Week high$18.35
52 Week low$5.00
52 Week low$5.00
Stock Snapshot
With a market cap of 9.84M, Sensei Biotherapeutics(SNSE) trades at $8.01. The stock has a price-to-earnings ratio of -0.38.
On 2025-11-17, Sensei Biotherapeutics(SNSE) stock moved within a range of $7.80 to $9.50. With shares now at $8.01, the stock is trading +2.6% above its intraday low and -15.7% below the session's peak.
Trading volume for Sensei Biotherapeutics(SNSE) stock has reached 22.85K, versus its average volume of 24.75K.
The stock's 52-week range extends from a low of $5.00 to a high of $18.35.
The stock's 52-week range extends from a low of $5.00 to a high of $18.35.
People also own
Based on the portfolios of people who own SNSE. This list is generated using Robinhood data, and it’s not a recommendation.